Ocean Biomedical, Inc. (OCEA) stock
OCEAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2025, quarter ended Mar 31, 2025Last filing: 10-Q on May 15, 2025
$0.00−0.00 (-16.67%)
Close on Oct 19, 2026Market cap $45.51KP/E –Yield –
Ocean Biomedical r&d expenses
Research and development expenses are spending on new products and technology.
Ocean Biomedical's R&D Expenses for the twelve months ending Mar 31, 2025 was $18.00K. For fiscal 2024 it was $26.00K, down 96.3% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $26.00K | -96.3% |
| FY2023 | Dec 31, 2023 | $709.00K | -91.6% |
| FY2022 | Dec 31, 2022 | $8.41M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2025 | Mar 31, 2025 | $18.00K | -30.8% |
| Q4 FY2024 | Dec 31, 2024 | $0 | -100.0% |
| Q3 FY2024 | Sep 30, 2024 | $0 | -100.0% |
| Q2 FY2024 | Jun 30, 2024 | $0 | -100.0% |
| Q1 FY2024 | Mar 31, 2024 | $26.00K | -83.9% |
| Q3 FY2023 | Sep 30, 2023 | $305.00K | -83.6% |
| Q2 FY2023 | Jun 30, 2023 | $28.00K | -99.1% |
| Q1 FY2023 | Mar 31, 2023 | $393.00K | -87.7% |
| Q4 FY2022 | Dec 31, 2022 | $161.00K | – |
| Q3 FY2022 | Sep 30, 2022 | $1.86M | – |
| Q2 FY2022 | Jun 30, 2022 | $3.19M | – |
| Q1 FY2022 | Mar 31, 2022 | $3.20M | – |
See a number that looks wrong?